Physician profile
Daniel M Rosenbaum
NPI 1194802579
$485.70
in general payments reported to CMS, 2019-2025
8 companies · $40.28 in 2025
The $40.28 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.79 · 2020: $55.31 · 2021: $135 · 2023: $106 · 2024: $125 · 2025: $40.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $159.01 | 2023-2024 | Kcentra, Haegarda |
| Astrazeneca Pharmaceuticals LP | $134.62 | 2021 | |
| Salvin Dental Specialties, INC. | $55.31 | 2020 | |
| Ucb, INC. | $46.34 | 2023 | Briviact |
| Octapharma USA, INC. | $25.35 | 2023 | Panzyga |
| Medtronic USA, INC. | $24.79 | 2019 | |
| Abbott Laboratories | $20.49 | 2025 | Infinity |
| Sk Life Science, INC. | $19.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rosenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.